[go: up one dir, main page]

ATE158279T1 - Cyanoguanidine als kaliumkanalblocker - Google Patents

Cyanoguanidine als kaliumkanalblocker

Info

Publication number
ATE158279T1
ATE158279T1 AT93917262T AT93917262T ATE158279T1 AT E158279 T1 ATE158279 T1 AT E158279T1 AT 93917262 T AT93917262 T AT 93917262T AT 93917262 T AT93917262 T AT 93917262T AT E158279 T1 ATE158279 T1 AT E158279T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
cyanoguanidine
potassium channel
formula
Prior art date
Application number
AT93917262T
Other languages
English (en)
Inventor
Stephen J Humphrey
Kaushik D Meisheri
James H Ludens
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE158279T1 publication Critical patent/ATE158279T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT93917262T 1992-08-13 1993-07-21 Cyanoguanidine als kaliumkanalblocker ATE158279T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92979592A 1992-08-13 1992-08-13

Publications (1)

Publication Number Publication Date
ATE158279T1 true ATE158279T1 (de) 1997-10-15

Family

ID=25458467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917262T ATE158279T1 (de) 1992-08-13 1993-07-21 Cyanoguanidine als kaliumkanalblocker

Country Status (16)

Country Link
US (1) US5567722A (de)
EP (1) EP0655057B1 (de)
JP (1) JPH08500111A (de)
CN (1) CN1039997C (de)
AT (1) ATE158279T1 (de)
AU (2) AU4530693A (de)
DE (1) DE69314041T2 (de)
DK (1) DK0655057T3 (de)
ES (1) ES2107049T3 (de)
GR (1) GR3025640T3 (de)
IL (1) IL106641A (de)
MX (1) MX9304882A (de)
MY (1) MY110826A (de)
TW (1) TW223017B (de)
WO (2) WO1994004499A1 (de)
ZA (1) ZA935619B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2116726T3 (es) * 1994-01-28 1998-07-16 Upjohn Co Cianoguanidinas utilizadas como bloqueadores del canal k.
AUPN193095A0 (en) * 1995-03-24 1995-04-27 Polychip Pharmaceuticals Pty Ltd Potassium ion channel blockers
AR008290A1 (es) * 1996-08-15 1999-12-29 Smithkline Beecham Corp Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios.
WO1998006398A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
EP1917244A2 (de) 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
CN113683535B (zh) * 2020-05-18 2022-08-30 中国药科大学 含氰胍结构的化合物及其制备方法与用途
CN112042664B (zh) * 2020-09-18 2022-06-10 广州古神生物科技有限公司 防霉抗菌剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
NL8000869A (nl) * 1979-02-16 1980-08-19 Eisai Co Ltd Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan.
JPH01166119A (ja) * 1987-12-23 1989-06-30 Hitachi Ltd データ入力装置の制御方式
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
AU623217B2 (en) * 1989-02-03 1992-05-07 Eli Lilly And Company (-)-n"-cyano-n-3-pyridyl-n'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers

Also Published As

Publication number Publication date
JPH08500111A (ja) 1996-01-09
DK0655057T3 (da) 1998-04-14
EP0655057B1 (de) 1997-09-17
WO1994004499A1 (en) 1994-03-03
DE69314041D1 (de) 1997-10-23
ES2107049T3 (es) 1997-11-16
ZA935619B (en) 1995-02-03
US5567722A (en) 1996-10-22
CN1039997C (zh) 1998-09-30
AU4530693A (en) 1994-03-15
DE69314041T2 (de) 1998-02-05
IL106641A0 (en) 1993-12-08
EP0655057A1 (de) 1995-05-31
TW223017B (de) 1994-05-01
IL106641A (en) 2001-01-11
WO1994004500A1 (en) 1994-03-03
CN1090575A (zh) 1994-08-10
MX9304882A (es) 1994-07-29
GR3025640T3 (en) 1998-03-31
MY110826A (en) 1999-05-31
AU4683193A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
NO20013379L (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
MA26996A1 (fr) Derives de glutaramide a substituant n-phenpropylcyclopentyle, servant d'inhibiteurs de nep pour un trouble d'eveil sexuel feminin
KR960702460A (ko) 티아졸리딘디온 및 이것을 함유하는 약제(new thiazolidindiones and drugs containing them)
NO883487L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
DK0759919T3 (da) Azolidindioner som antihyperglykæmiske midler
ES2141329T3 (es) Antifungicos azolicos solubles en agua.
ES2191985T3 (es) S-oxido de tetrahidrotiopirano feniloxazolidinonas.
DE69314041D1 (de) Cyanoguanidine als kaliumkanalblocker
AU7615794A (en) Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
JPS5750989A (en) Imidazole compound
ATE176905T1 (de) Pyrimidine-cyanoguanidine als kaliumkanalblocker
MY131544A (en) Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
UA43338C2 (uk) Похідні бензолу
DE69502584D1 (de) Cyanoguanidine als k-kanal-blocker
ES8100304A1 (es) Un procedimiento para preparar derivados de indol policiclicos
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
DK0646116T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af bis-aza-bicycliske anxiolytiske midler
NO922523D0 (no) Aminopyrimidinkarboksamiddrivater med terapeutisk virkning
SE7713864L (sv) Nortropinkarbazatderivat och forfarande for framstellning av dem
ES2156617T3 (es) Derivados de 1,9-diazabiciclo(4.3.0)nona-3,8-dieno.
TH14335A (th) ไซแอโนกัวนิดีนเป็นตัวสกัดกั้นช่องผ่านออกของโพแทสเซียม

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee